NDC 0641-6103-01 - ROBAXIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6103
- Requested NDC
- 0641-6103-01
- Package NDCs from labels
- 0641-6103-01, 0641-6103-10, 0641-6103-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROBAXIN Injectable (methocarbamol injection, USP) | Hikma Pharmaceuticals USA Inc. | 2024-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6103-01 | ROBAXIN | 10 mL in 1 VIAL | INJECTION | 10 | 8 | |
| 0641-6103-10 | ROBAXIN | 10 in 1 CARTON | INJECTION | 10 | 8 | |
| 0641-6103-25 | ROBAXIN | 25 in 1 CARTON | INJECTION | 25 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6103-01 | ML - Milliliter | 0641-6103 | fea093a9-e51d-4877-9285-77155bc4380f | 1 | 2013-02-13 |
| 0641-6103-10 | ML - Milliliter | 0641-6103 | 86079302-612f-4f5d-8af4-0b2d1fa573d8 | 1 | 2024-03-12 |
| 0641-6103-25 | ML - Milliliter | 0641-6103 | e99128e7-032f-45f6-bb13-8e212a583b26 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHOCARBAMOL | ACTIVE INGREDIENT | 125OD7737X | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| METHOCARBAMOL | ACTIVE MOIETY | 125OD7737X | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 300 | INACTIVE INGREDIENT | 5655G9Y8AQ | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | b72a3fff-9710-4c60-8ca6-ed428377fc24 | 2026-03-16 | Warnings, Adverse reactions | 125OD7737X |
| ATMEKSI | METHOCARBAMOL | Rosemont Pharmaceuticals LLC | 62de7345-613b-4838-96e5-aceca3cea6b2 | 2026-03-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Advanced Rx of Tennessee, LLC | 4cefe51c-d824-a862-e063-6394a90a7717 | 2026-03-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | d3448618-c9b4-4cb9-a30e-1afc8197cfe1 | 2026-03-11 | Warnings, Adverse reactions | 125OD7737X |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 44f264fd-bf40-bed9-e063-6294a90ac44a | 2026-03-05 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 311c79a5-1447-4fef-8726-ae003ef64db5 | 2026-03-01 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | 4b1d8ac6-d25d-1c37-e063-6394a90aba29 | 2026-02-18 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 288a3bcd-a2c8-4a9b-9602-59c0493b4a8d | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 3b0e60a7-3cff-4665-a473-ad3257619cdd | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 943fe701-5d7d-4abe-a529-c5a548e94bc6 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 440bf1ba-a704-4c35-bece-0a0987fc0c11 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 12c8da39-3a0e-4303-9655-29dd83507837 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 4abc29e9-a0cc-06cf-e063-6294a90ad874 | 2026-02-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Major Pharmaceuticals | 2df34fa7-9cdc-4be4-ac6f-577122462606 | 2026-02-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bostal LLC | d8f10211-f96e-4cf3-9b49-986eb51b703d | 2026-02-04 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 125OD7737X |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | UNICHEM PHARMACEUTICALS (USA), INC. | 5777cbb0-b5fd-4b36-ac1d-bc105fe96888 | 2026-01-19 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.